Implantable drug depots with external control of drug release which can replace repetitive injections.
| Organization: | ETH Zurich - ETH transfer, Zurich, CH |
| I.P. Brief: | The IP discloses a drug depot with embedded therapeutic substance that can be released in a dose-dependent way by the oral administration of a small molecule, an activator. The implanted drug depot may relief patients from repetitive injections and may lead to considerable improvement of their life. |
| Keywords: | Drug depot, biopharmaceuticals, drug implant, transdermal, patent life cycle management, galenic formulation, hydrogel, dose regulation, subcutaneous, intra muscular |
| Primary Industry: | Biotech&Medical, Pharmaceuticals |
Full IP Descriptions available on-site.